Most patients notice appetite suppression within the first one to two weeks, even at the 2.5mg starting dose
The landmark SELECT trial, involving over 17,000 participants, demonstrated a remarkable 20% reduction in major adverse cardiovascular events, including heart attack, stroke, or cardiovascular death, in overweight or obese adults with established CVD
This compensatory response is called reflex tachycardia
GLP-3 medications take this multiple-target strategy a step further
What the science supports clearly is hydration and the correction of nutrient shortfalls
These gastrointestinal side effects can disrupt nutrient absorption and make you feel tired